News in brief President Obama signs 21st Century Cures Act The legislation will expedite the drug approval process and provide funding for cancer research and opioid addiction treatment. Dec. 14, 2016Wednesday The DO Staff Contact The DO Staff Facebook Twitter LinkedIn Email President Barack Obama signed the 21st Century Cures Act into law on Tuesday. The law contains provisions designed to expedite the drug approval process and provides funding for cancer research, opioid addiction treatment and the Precision Medicine and BRAIN initiatives, according to the Washington Post. The $6.3-billion law includes the following, according to Kaiser Health News: $4.8 billion over 10 years to the National Institutes of Health. $1 billion over two years for states to address opioid abuse and addiction. Proponents of the law say it will help patients get the drugs they need more quickly, spur innovations in cancer research and help combat the opioid epidemic. Critics say the law could put drugs in the hands of patients before the drugs have been properly vetted as safe. They also note that because the law pulls $3.5 billion from the Prevention and Public Health Fund, fewer resources will be available for preventive medicine initiatives and combatting public health threats going forward. To learn more, read about the 21st Century Cures Act in the Washington Post, NBC News and Kaiser Health News. More in Newsbriefs Free holistic residency application review platform will soon be available for residency programs that use ERAS Cortex, an AI-enabled platform, is designed to provide technology-assisted holistic review by streamlining application screening and review. AOA’s research grants workshop will guide applicants through funding process The Nov. 14 workshop will cover important topics such as RFA/NOFOs and available funding amounts. Previous article'Discrimination affects us all': When physicians experience prejudice Next articleStudy illustrates challenges of billing and coding for social determinants of health
Free holistic residency application review platform will soon be available for residency programs that use ERAS Cortex, an AI-enabled platform, is designed to provide technology-assisted holistic review by streamlining application screening and review.
AOA’s research grants workshop will guide applicants through funding process The Nov. 14 workshop will cover important topics such as RFA/NOFOs and available funding amounts.